Bioblast Pharma Ltd. (ORPN) Dipped -6.4% or -0.81 To Price $11.79 On Monday


Bioblast Pharma Ltd. (ORPN) dipped -6.4% or -0.81 to $11.79. It is near 19048 shares traded, which is 39.4% compare to the average total volume 48346. The market cap of ORPN is $619020. The year to date change is 78.85%. The 52 week price range is from $6.19 to $30.0. Price of ORPN have changed 24.02% during last week. It have changed 45.83% over last month, 35.78% over last 3 months, 24.60% over last 6 months and -48.70% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ORPN is 9.18. It is -22.14% below current price. The 200-day Moving Averages for ORPN is 11.14. It is -5.51% below current price. The 52-week High is 30.0. It is 154.45% from the current price. The 52-week Low is 6.19. It is -47.50% from current price.

There are some statistics of ORPN. It is has market cap $619020. The share outstanding is 52486. The average volume is 48346. The percent of top 15 Institution holding is 4.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ORPN is -106.14%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ORPN is -92.38%.


Tags:

Share this post